Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

6.71
BATS BZX Real-Time Price
As of 11:00am ET
 -0.01 / -0.15%
Today’s Change
3.50
Today|||52-Week Range
11.80
-6.81%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2011
Quarter 4
2011
Quarter 1
2012
Quarter 2
2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization39.0K43.1K42.6K138.0K
 
 
 
 
 
 
Operating ExpensesGross Income-39.0K-43.1K-42.6K-138.0K
 
 
 
 
 
General Expenses2.2M2.5M2.4M5.6M
 
 
 
 
 
Research And Development1.0M1.1M940.6K2.8M
 
 
 
 
 
Total Operating Expenses2.2M2.5M2.5M5.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.2M-2.5M-2.5M-5.8M
 
 
 
 
 
Extraordinary Credit5.3M0.005.6M595.0K
 
 
 
 
Extraordinary Charge0.00-32.6M0.000.00
 
 
Interest Expense On Debt949.00--6.2K29.0K
 
 
 
 
Other Expenses5.7K-4.3K3.6K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income3.1M-35.1M3.1M-5.2M
 
 
 
 
 
Net Income3.1M-35.1M3.1M-5.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS13.0M13.0M14.5M31.9M
 
 
 
 
 
Shares To Calculate EPS Diluted13.6M13.0M17.3M31.9M
 
 
 
 
 
 
Earnings Per ShareEPS$0.24--$0.20-$0.16
 
 
 
 
EPS Diluted$0.24-$2.72$0.20-$0.16